过滤
关闭导航

疫苗研发与生产, Vaccine Manufacturing

包含疫苗研发与生产试剂、培养基、佐剂乳液,细菌佐剂,碳水化合物佐剂,细胞因子佐剂,矿物质盐佐剂(Adjuvant emulsions,Bacteria-derived adjuvants,Carbohydrate adjuvants,Cytokines as adjuvants,Mineral salt adjuvants)等多种产品。

浏览为
排序由
显示 每页

sTRAIL Receptor-2 (DR5) human,[DR5, KILER, TNFRSF10B];recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture

SRP3165
别名:DR5, KILER, TNFRSF10B, soluble TRAIL Receptor-2;可溶性肿瘤坏死因子相关的凋亡诱导配体受体2(sTRAIL-R2)
¥4,396.12

TACI human,[TNFRSF13B];recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture

SRP3166
别名:TNFRSF13B;Transmembrane activator and CAML interactor;NACRES NA.32
¥4,550.23

TL-1A human,[TNFSF15, VEGI];recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture

SRP3175
TL-1A属于配体的TNF超家族。 重组人TL-1A是具有194个氨基酸残基的22.0kDa多肽。NACRES: NA.32
¥4,396.12

TLR-3 human,recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture

SRP3176
别名:CD283 antigen;Toll-like receptor 3;NACRES NA.32

TLR-3是与微生物病原体和双链RNA(dsRNA)病毒结合并发出信号的I型单程受体。 重组人TLR-3是77.0kDa的糖蛋白,其包含681个残基,其包含TLR-3细胞外结构域。
¥5,350.00

TRAIL from mouse,[Apo2 Ligand, TL2, TNFSF10];recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC), suitable for cell culture

SRP3237
别名:Apo2 Ligand, TL2, TNF-related apoptosis-inducing Ligand, TNFSF10;NACRES NA.32
¥4,396.12

TWEAK Receptor human,[FGF-inducible 14, TNFRSF12A];recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), suitable for cell culture

SRP3180
别名:FGF-inducible 14, TNF-related weak inducer of apoptosis receptor, TNFRSF12A;NACRES NA.32
¥4,396.12

人白细胞介素-2,Interleukin-2 human [IL-2, IL2, TCGF, hIL-2];recombinant, expressed in E. coli, ~10000 U/mL

57600
别名:人白介素2;人IL-2;CAS号: 94218-72-1 MDL编号: MFCD00165721 NACRES: NA.32
¥9,601.46